childhood
period
innat
adapt
immun
system
matur
start
birth
infanc
high
risk
respiratori
tract
infect
rti
mainli
virus
bacteria
earli
protect
mani
infecti
diseas
come
mother
transport
matern
antibodi
via
placenta
pregnanc
breast
milk
birth
immun
system
gradual
matur
infanc
vaccin
come
stimul
protect
immun
respons
vitamin
believ
major
role
improv
immun
function
reduct
inflamm
activ
metabolit
oh
calcitriol
document
mediat
innat
adapt
immun
system
trigger
effect
antimicrobi
pathway
bacteri
viral
fungal
pathogen
cell
innat
immun
system
purpos
review
present
recent
data
role
vitamin
immun
infect
associ
incid
sever
rti
childhood
especi
earli
year
aim
narr
review
order
summar
recent
publish
regard
potenti
associ
low
oh
circul
level
rti
upper
lower
children
adolesc
year
possibl
role
vitamin
supplement
prevent
treatment
childhood
rti
search
limit
publish
english
languag
regardless
settingregion
lowmiddl
highincom
countri
provid
comprehens
overview
avail
evid
electron
search
conduct
identifi
studi
use
follow
databas
pubm
scopu
googl
scholar
search
term
vitamin
respiratori
tract
infect
tuberculosi
influenza
infanc
childhood
use
variou
combin
duplic
exclud
inclus
criteria
follow
studi
differ
level
evid
includ
random
clinic
trial
observ
casecontrol
cohort
studi
infect
upper
lower
respiratori
tract
relat
oh
statusstudi
vitamin
supplement
either
alon
combin
anoth
intervent
prevent
rtistudi
age
year
publish
includ
one
small
studi
conduct
one
great
import
studi
publish
english
languag
exclud
studi
children
asthma
asthma
exacerb
wheez
preexist
ill
ricket
hiv
also
exclud
studi
oh
statu
pregnanc
includ
studi
cord
blood
associ
rti
infanc
exclud
review
metaanalysi
letter
anim
studi
first
scan
conduct
abstract
relev
studi
full
text
select
find
use
narr
review
vitamin
fatsolubl
steroid
endocrin
function
mainli
synthes
skin
exposur
ultraviolet
radiat
sun
absorb
food
sourc
two
major
form
cholecalciferol
ergocalciferol
vitamin
biolog
inact
requir
sequenti
enzymat
convers
liver
kidney
becom
activ
vitamin
produc
skin
absorb
transport
main
carrier
protein
vitamin
dbind
protein
liver
first
hydroxyl
catalyz
enzym
take
place
produc
releas
oh
circul
metabolit
circul
marker
oh
statu
depend
need
oh
undergo
second
hydroxyl
kidney
mitochondri
cytochrom
enzym
convert
oh
product
tightli
feedbackregul
main
role
regul
calciumphosph
bone
homeostasi
genom
activ
number
gene
target
tissu
intestin
bone
kidney
parathyroid
gland
howev
enzym
activ
studi
use
varieti
tissu
reveal
synthesi
oh
occur
sever
key
peripher
site
includ
cell
immun
system
contrast
kidney
support
system
endocrin
action
oh
extraren
metabolit
appear
act
autocrin
paracrin
fashion
modul
cell
differenti
andor
function
local
level
action
mediat
bind
oh
hormon
nuclear
receptor
vdr
lead
regul
target
gene
transcript
turn
put
plasma
membraneassoci
receptor
vdr
mem
initi
signal
transduct
pathway
gener
rapid
biolog
cellular
respons
regul
transcript
activ
cellspecif
oh
inhibit
pth
secret
promot
innat
immun
insulin
secret
inhibit
adapt
immun
due
wide
distribut
vdr
cell
tissu
biolog
action
vitamin
extend
mani
system
includ
adapt
innat
immun
system
sinc
vdr
express
variou
immun
cell
includ
b
antigenpres
cell
believ
role
improv
immun
function
reduct
inflamm
discoveri
moreov
vitamin
induc
antimicrobi
peptid
gene
express
explain
part
antibiot
effect
vitamin
greatli
renew
interest
abil
vitamin
improv
immun
function
current
research
indic
regul
biolog
import
respons
innat
immun
system
infect
defici
may
lead
suboptim
respons
bacteri
viral
infect
mention
serum
oh
concentr
best
marker
defin
vitamin
statu
refer
standard
use
clearli
state
literatur
appear
wide
variabl
lower
upper
limit
healthi
serum
oh
level
reason
yet
intern
consensu
optim
concentr
adult
children
sever
author
societi
defin
vitamin
defici
serum
level
oh
ngml
nmoll
sinc
level
meet
need
popul
regard
bone
health
sever
vitamin
defici
defin
ngml
nmoll
oh
cutoff
risk
ricket
high
bonecentr
guidelin
recommend
target
oh
concentr
ngml
nmoll
agedepend
daili
vitamin
dose
iu
guidelin
focus
pleiotrop
effect
vitamin
recommend
target
oh
concentr
ngml
nmoll
age
bodi
weight
diseasestatu
ethnicitydepend
vitamin
dose
rang
iuday
recent
year
grow
interest
vitamin
pediatr
patient
due
epidemiolog
report
suggest
may
play
role
innat
immun
specif
studi
shown
vitamin
might
play
signific
immunomodulatori
role
improv
incid
sever
bacteri
viral
infect
recent
review
suggest
abil
vitamin
influenc
normal
human
immun
highli
depend
oh
statu
individu
defici
insuffici
may
associ
increas
autoimmun
infect
histor
link
vitamin
innat
immun
function
identifi
use
cod
liver
oil
treatment
children
tuberculosi
nowaday
report
vitamin
regul
innat
immun
increas
product
antimicrobi
peptid
subsequ
kill
bacteria
innat
immun
system
immedi
nonspecif
first
line
defens
pathogen
includ
antimicrobi
peptid
respons
circul
level
oh
activ
metabolit
vitamin
potent
stimul
genet
express
product
effector
innat
immun
antimicrobi
peptid
amp
human
monocyt
neutrophil
human
cell
line
happen
suffici
circul
level
oh
necessari
effector
innat
immun
amp
directli
kill
broad
spectrum
microb
includ
gramposit
gramneg
bacteria
fungi
certain
virus
amp
extrem
divers
group
small
protein
consid
togeth
nativ
antimicrobi
activ
two
major
famili
amp
character
mammal
cathelicidin
defensin
pathogen
pathogenassoci
molecular
pattern
pamp
trigger
pathogen
recognit
tolllik
receptor
human
result
increas
express
vdr
induc
product
activ
vitamin
complex
vitamin
dvdrrxr
transloc
nucleu
bind
vitamin
respons
element
vdre
initi
transcript
vdrrespons
gene
cathelicidin
betadefensin
promot
product
protein
human
cathelicidin
antimicrobi
peptid
gene
found
express
neutrophil
monocyt
dendrit
cell
lymphocyt
natur
killer
cell
epitheli
cell
respiratori
gastrointestin
tract
cathelicidin
potent
antiendotoxin
direct
antimicrobi
activ
effect
methicillinresist
aureu
mrsa
may
caus
seriou
ill
pneumonia
also
broad
spectrum
antibacteri
activ
activ
combin
oh
stimul
express
correl
enhanc
monocytemedi
kill
mycobacterium
tuberculosi
mtb
monocyt
lung
intestin
epitheli
cell
oh
report
major
regul
addit
oh
vdr
action
also
report
converg
tlrinduc
interleukin
beta
signal
pathway
induc
express
antimicrobi
peptid
defensin
beta
monocyt
monocyt
macrophag
crucial
member
innat
immun
compart
abl
phagocytos
pathogen
sens
pamp
express
pathogen
effect
vitamin
macrophag
function
central
mani
new
observ
implic
vitamin
regul
immun
respons
common
natur
killer
nk
cell
cytotox
tlymphocyt
cytotox
tcell
macrophag
monocyt
precursor
play
central
role
initi
nonspecif
immun
respons
pathogen
addit
macrophag
interfac
adapt
immun
system
util
phagocyt
materi
antigen
present
lymphocyt
tcell
stimul
tolllik
receptor
human
monocytederiv
macrophag
bacteri
lipopeptid
lead
induct
coexpress
vdr
turn
intracrin
induct
cathelicidin
gene
product
express
mycobacteri
kill
insid
phagolysosom
seri
event
occur
provid
adequ
free
oh
substrat
mitochondri
intracrin
synthesi
action
oh
turn
depend
serum
oh
concentr
vitamin
vdr
may
also
play
role
regul
cell
prolifer
differenti
express
vdr
activ
prolifer
b
lymphocyt
suggest
oh
antiprolif
effect
cell
oh
also
regul
tcell
develop
migratori
function
oh
decreas
prolifer
cell
also
inhibit
product
ifnc
cell
vitamin
administr
markedli
enhanc
transform
growth
transcript
result
immunosuppress
action
increas
cell
function
vdr
mrna
express
human
primari
b
cell
low
level
upregul
follow
stimul
presenc
oh
indic
b
cell
may
abl
respond
autocrineintracrin
way
oh
vdr
upregul
activ
oh
need
inhibit
b
cell
prolifer
may
threshold
level
vdr
antiprolif
effect
oh
inhibit
b
cell
prolifer
associ
apoptosi
activ
divid
b
cell
might
come
inhibit
previou
cycl
b
cell
enter
cell
cycl
year
ago
use
antibiot
cod
liver
oil
rich
sourc
vitamin
sunlight
use
treat
tuberculosi
tb
presentday
studi
concern
potenti
correl
oh
statu
tb
pediatr
popul
limit
retrospect
studi
found
high
percentag
vitamin
deficiencyinsuffici
children
activ
latent
tb
infect
signific
season
variat
howev
control
group
children
mostli
minor
group
black
african
south
asian
anoth
studi
refuge
children
found
similar
result
oh
concentr
significantli
lower
children
activ
latent
tb
infect
compar
healthi
control
moreov
larger
studi
children
nativeborn
immigr
reveal
posit
correl
low
oh
tb
infect
hypovitaminosi
significantli
associ
activ
latent
tb
children
compar
healthi
control
india
three
studi
investig
serum
oh
concentr
children
osteoarticular
tb
intrathorac
tb
agarw
studi
reveal
hypovitaminosi
patient
discov
discern
differ
oh
level
respect
sex
age
site
infect
similarli
dabla
studi
case
vitamin
defici
lower
level
serum
oh
compar
healthi
control
irrespect
gender
ethnic
age
likewis
khandelw
et
al
found
case
deficientinsuffici
vitamin
time
taken
cure
tb
depend
basal
serum
oh
concentr
higher
median
baselin
level
need
shorter
time
howev
vitamin
administ
one
group
outcom
differ
placebo
recent
observ
studi
evalu
serum
oh
concentr
children
activ
tb
compar
latent
tb
nontb
pneumonia
healthi
control
author
analysi
show
higher
percentag
vitamin
ddefici
children
found
activ
tb
group
compar
clinic
categori
suggest
posit
correl
hypovitaminosi
activ
tb
hand
two
studi
found
correl
tb
case
vitamin
first
evalu
serum
oh
concentr
infant
toddler
age
year
without
activ
tb
pune
india
found
group
equal
vitamin
defici
high
percentag
studi
conduct
children
year
botswana
africa
burden
tb
infect
among
highest
world
found
signific
differ
oh
statu
two
group
crosssect
analysi
baselin
data
mongolian
schoolchildren
investig
risk
factor
mtb
infect
found
household
contact
case
pulmonari
tb
vitamin
defici
household
exposur
tobacco
smoke
increas
age
independ
risk
factor
infect
moreov
found
associ
risk
mtb
infect
gender
socioeconom
factor
presenc
bcg
scar
season
bmi
vitamin
defici
passiv
smoke
increas
age
independ
risk
factor
infect
far
prevent
treatment
vitamin
concern
small
random
studi
children
conduct
cholecalciferol
iu
ad
daili
week
tb
treatment
group
acceler
clinic
radiolog
improv
group
compar
receiv
standard
treatment
alon
recent
doubleblind
placebocontrol
studi
conduct
schoolchildren
latent
tb
infect
supplement
iu
vitamin
daili
month
reveal
benefici
statist
signific
effect
serum
oh
concentr
furthermor
children
trend
reduct
tuberculin
skin
test
convers
rate
compar
placebo
group
result
indic
signific
associ
presenc
tb
vitamin
defici
other
show
nonsignific
associ
moreov
result
indic
vitamin
supplement
may
benefici
tb
treatment
prevent
although
studi
children
limit
small
sampl
size
studi
need
evalu
role
vitamin
prevent
treatment
tb
infect
age
group
theori
improv
vitamin
statu
could
increas
innat
immun
consequ
play
role
primari
prevent
tb
infect
children
great
import
especi
poor
countri
high
tb
endem
countri
otiti
media
om
refer
inflamm
middl
ear
common
infect
childhood
may
due
bacteria
pneumococci
streptococci
meningococci
virus
om
three
main
type
acut
otiti
media
aom
otiti
media
effus
ome
chronic
secretori
otiti
media
csom
childhood
mani
risk
factor
develop
om
upper
respiratori
tract
infect
urti
viral
bacteri
common
risk
aom
ome
csom
increas
winter
period
studi
investig
associ
vitamin
develop
om
children
cayir
colleagu
first
assess
role
vitamin
children
aom
studi
children
age
year
old
found
oh
concentr
significantli
lower
case
control
anoth
studi
case
ome
candid
adenotonsillectomi
conclud
mean
level
oh
slightli
lower
case
control
group
ie
without
signific
differ
two
group
howev
author
comment
patient
ome
measur
oh
necessari
defici
treat
similarli
anoth
small
studi
children
adenotonsillar
hypertrophi
ome
reach
conclus
even
though
lower
serum
level
oh
compar
children
adenotonsillar
hypertrophi
statist
signific
adjust
season
stronger
evid
come
case
control
studi
higher
serum
oh
concentr
without
supplement
associ
lower
risk
chronic
otiti
media
effus
come
preschool
children
propos
come
could
reduc
increas
serum
oh
concentr
increas
sun
exposur
higher
dietari
intak
vitamin
supplement
recent
studi
strongli
suggest
signific
associ
vitamin
defici
followup
outcom
ome
well
strong
effect
vitamin
ome
prognosi
howev
one
studi
report
slightli
contradictori
result
studi
report
neg
correl
vitamin
chronic
ome
lost
adjust
age
despit
conclud
vitamin
defici
might
correl
csom
diseas
sever
particularli
durat
ear
discharg
two
studi
found
evalu
whether
vitamin
supplement
could
effect
reduc
reoccurr
om
children
age
year
cayir
colleagu
evalu
serum
oh
level
case
recurr
om
compar
healthi
children
case
averag
significantli
lower
serum
oh
compar
control
addit
found
supplementari
vitamin
treatment
defici
case
could
decreas
rate
recurr
om
followup
period
conclud
coadministr
supplementari
vitamin
togeth
convent
treatment
appropri
manag
urti
otiti
media
studi
marchisio
et
al
involv
children
histori
recurr
aom
half
children
randomli
receiv
oral
iu
daili
vitamin
half
receiv
placebo
period
month
children
receiv
vitamin
supplement
rais
serum
oh
level
ngml
significantli
reduc
number
uncompl
aom
compar
placebo
also
significantli
lower
level
serum
oh
end
studi
period
author
suggest
need
systemat
vitamin
supplement
popul
commonli
found
vitamin
hypovitaminosi
reach
level
ngml
overal
result
indic
strong
associ
om
low
serum
oh
concentr
patient
om
seem
vitamin
insufficiencydefici
possibl
lead
higher
incid
om
longer
durat
ill
repeat
aom
episod
henc
vitamin
supplement
might
effect
adjuv
therapi
treatment
om
doubleblind
casecontrol
studi
need
unequivoc
determin
whether
prevent
overal
aom
reduc
recurr
episod
children
addit
optim
dosag
supplement
also
need
determin
exist
data
enough
evid
vitamin
supplement
guidelin
children
om
acut
pharyngotonsil
common
upperairway
infect
infant
children
defin
infect
tonsil
pharynx
etiolog
infect
usual
viral
rhinoviru
epsteinbarr
viru
parainfluenza
influenza
among
bacteri
pharyngotonsil
import
caus
group
betahemolyt
streptococci
common
schoolag
children
typic
occur
winter
fall
children
recurr
episod
pharyngotonsil
mean
least
seven
episod
per
year
least
five
episod
acut
tonsil
per
year
two
consecut
year
least
three
episod
acut
tonsil
per
year
three
consecut
year
studi
sought
determin
role
vitamin
infant
children
diagnos
acut
recurr
tonsil
pharyngotonsil
studi
schoolag
children
undergo
tonsillectomi
due
breath
difficulti
andor
recurr
tonsil
found
oh
level
ngml
nearli
ngml
anoth
studi
show
children
recurr
episod
tonsillopharyng
period
serum
oh
level
lower
healthi
children
similarli
anoth
studi
investig
serum
oh
concentr
among
children
recurr
tonsil
observ
oh
level
candid
tonsillectomi
significantli
lower
less
three
episod
per
year
howev
one
casecontrol
trial
turkey
children
undergo
tonsillectomi
found
signific
differ
mean
serum
oh
concentr
compar
control
overal
accord
limit
studi
vitamin
insufficiencydefici
seem
preval
children
recurr
tonsil
recurr
tonsillopharyng
candid
tonsillectomi
none
studi
other
investig
whether
vitamin
supplement
could
reduc
frequenc
episod
rate
tonsillectomi
oper
studi
need
carri
futur
acut
rhinosinus
ar
inflamm
upper
airway
sinus
common
problem
pediatr
popul
present
thick
nasal
mucu
rhinorrhea
cough
pain
fever
symptom
usual
associ
viral
urti
ar
character
symptom
last
less
week
complet
resolut
usual
aris
viral
infect
symptom
persist
longer
without
complet
resolut
case
chronic
rhinosinus
cr
probabl
brought
bacteri
infect
cr
divid
three
clinic
subtyp
cr
without
nasal
polyp
crssnp
cr
nasal
polyp
crswnp
allerg
fungal
rhinosinus
afr
term
sinus
replac
term
rhinosinus
mainli
nasal
mucosa
alway
present
diseas
pediatr
popul
studi
associ
vitamin
rhinosinus
limit
one
studi
evalu
oh
children
year
old
three
subtyp
afr
crswnp
crssnp
compar
control
differ
found
mean
serum
oh
level
patient
crssnp
control
wherea
children
crswnp
afr
vitamin
defici
anoth
studi
divid
children
year
old
ar
complic
presept
cellul
ar
without
complic
compar
healthi
control
main
find
vitamin
defici
prove
risk
factor
develop
ar
complic
howev
ar
group
lower
serum
oh
concentr
compar
control
author
suggest
vitamin
supplement
might
reduc
rhinosinus
develop
complic
pediatr
popul
far
studi
vitamin
supplement
adult
carri
show
signific
improv
symptom
rhinosinus
mainli
smell
disturb
allerg
rhiniti
studi
children
chronic
recurr
sinus
util
vitamin
supplement
adjunct
therapi
togeth
cod
liver
oil
vitamin
conduct
report
decreas
sinu
symptom
fewer
episod
acut
sinus
fewer
pediatr
visit
sever
drawback
includ
extrem
small
sampl
size
four
children
studi
design
outcom
base
questionnair
fill
parent
without
serum
sampl
obtain
patient
low
serum
oh
present
pediatr
patient
crswnp
afr
unclear
whether
supplement
vitamin
children
acut
chronic
rhinosinus
would
improv
symptom
thu
clinic
benefit
howev
improv
serum
oh
concentr
might
use
adjunct
treatment
wellknown
antiinflammatori
properti
nevertheless
case
control
studi
carri
pediatr
popul
order
clarifi
hypothesi
good
deal
research
conduct
regard
correl
alri
oh
concentr
infant
children
howev
mix
result
three
studi
found
serum
oh
concentr
significantli
lower
infant
children
alri
compar
healthi
control
sever
vitamin
defici
togeth
nonexclus
breastfeed
may
increas
risk
factor
alri
mcnalli
colleagu
hand
report
differ
mean
oh
concentr
children
alri
control
also
note
children
alri
admit
pediatr
intens
care
unit
vitamin
defici
henc
suggest
possibl
associ
immunomodulatori
properti
vitamin
sever
diseas
furthermor
anoth
studi
turkey
signific
differ
term
oh
concentr
diseas
sever
found
case
lower
respiratori
tract
infect
lri
year
age
healthi
children
howev
rate
vitamin
defici
insuffici
high
group
respect
lead
author
recommend
routin
screen
vitamin
defici
children
lri
vitamin
supplement
children
especi
winter
month
similarli
one
studi
canada
one
iran
found
signific
differ
case
control
term
oh
serum
level
uncompl
alri
primari
viral
bronchiol
children
less
year
old
japan
small
casecontrol
studi
show
children
alri
lower
oh
concentr
ngml
mainli
need
supplementari
oxygen
ventil
manag
sinc
vitamin
ddefici
infant
breastf
author
suggest
vitamin
supplement
infant
breastfeed
mother
order
prevent
sever
complic
alri
likewis
anoth
casecontrol
studi
newborn
alrti
admit
neonat
intens
care
unit
suggest
low
serum
oh
concentr
ngml
might
associ
higher
risk
alrti
newborn
sinc
median
oh
level
lower
infect
control
addit
oh
level
mother
ill
infant
also
found
lower
control
thu
suggest
vitamin
supplement
pregnanc
birth
may
enhanc
respiratori
health
newborn
studi
investig
relationship
vitamin
defici
bronchiol
infant
month
old
found
serum
oh
averag
much
lower
moderatesever
group
mild
one
moreov
number
patient
oh
level
latter
group
significantli
higher
author
henc
associ
vitamin
defici
sever
bronchiol
hospit
although
result
link
vitamin
defici
incid
sever
pneumonia
consist
definit
trend
toward
associ
mean
vitamin
could
impact
host
respons
infect
gener
sever
studi
attempt
find
associ
serum
oh
lri
thu
far
yield
unequivoc
evid
howev
sinc
lri
respons
great
extent
year
age
mortal
correct
vitamin
defici
prove
impact
prevent
sever
simpl
intervent
would
repres
major
public
health
outcom
although
studi
shown
associ
vitamin
defici
lri
trial
carri
order
evalu
direct
effect
vitamin
supplement
young
children
diagnos
lri
vitamin
intak
children
younger
year
age
admit
hospit
either
bronchiol
pneumonia
compar
studi
unmatch
control
group
without
respiratori
infect
data
collect
children
alri
control
result
show
children
alri
lower
vitamin
intak
iukgday
control
iukgday
control
factor
might
affect
incid
alri
conclud
intak
iukgday
four
time
suscept
alri
higher
intak
ci
henc
higher
vitamin
intak
current
recommend
might
need
offer
protect
diseas
alri
find
random
doubleblind
placebocontrol
trial
vitamin
therapi
bronchiol
infant
month
age
conduct
egypt
support
theori
author
report
group
receiv
iukgday
day
signific
improv
time
taken
resolut
diseas
return
oral
feed
well
durat
hospit
compar
placebo
trial
assess
therapeut
efficaci
vitamin
supplement
pneumonia
trial
kabul
children
less
year
old
pneumonia
found
differ
time
recoveri
take
bolu
iu
togeth
antibiot
treatment
placebo
group
yet
risk
children
repeat
episod
follow
month
significantli
lower
vitamin
group
author
set
randomli
assign
infant
less
year
old
receiv
quarterli
dose
iu
vitamin
placebo
period
month
vitamin
supplement
improv
incid
sever
pneumonia
hospit
admiss
mortal
similarli
two
trial
conduct
india
evalu
oral
vitamin
supplement
infant
children
less
year
age
sever
pneumonia
vitamin
supplement
iu
daili
day
singl
mega
dose
iu
enrol
benefici
effect
resolut
sever
pneumonia
age
overal
studi
conduct
investig
whether
vitamin
supplement
would
use
prevent
treatment
outcom
improv
lri
appear
reach
solid
conclus
type
suffici
evid
show
benefici
effect
vitamin
supplement
incid
prevent
pneumonia
though
among
children
bronchiol
supplement
appear
shorten
recoveri
period
hospit
time
nevertheless
robustli
power
random
control
trial
requir
evalu
dose
frequenc
durat
vitamin
intak
determin
efficaci
prevent
treatment
lri
children
studi
associ
also
found
infant
alri
cord
blood
matern
oh
concentr
prospect
studi
neonat
report
plasma
level
oh
ngml
birth
increas
risk
rsv
lri
first
year
life
compar
newborn
concentr
gml
similar
birth
cohort
studi
newborn
countri
abund
sunlight
like
saudi
arabia
reveal
lower
cord
blood
oh
concentr
associ
increas
risk
sever
alri
first
year
life
infant
develop
bronchiol
pneumonia
lower
cold
blood
concentr
oh
compar
likewis
anoth
prospect
birth
cohort
studi
motherinf
pair
low
oh
concentr
deliveri
associ
higher
lri
risk
infant
first
year
life
associ
stronger
children
born
fall
anoth
birth
cohort
studi
motherinf
pair
low
oh
concentr
deliveri
ngml
associ
higher
risk
rti
age
month
rel
poor
lung
perform
age
month
studi
show
strong
revers
associ
cord
blood
oh
level
alri
present
within
first
year
life
sinc
cord
blood
oh
concentr
depend
mother
concentr
suggest
supplement
pregnanc
would
result
higher
matern
level
consequ
would
benefici
effect
prevent
sever
lri
earli
childhood
world
health
organ
defin
influenza
infecti
diseas
caus
influenza
viru
four
type
b
c
howev
influenza
b
virus
circul
caus
season
epidem
diseas
age
group
clinic
trial
assess
effect
vitamin
supplement
protect
influenza
viru
infect
infant
schoolchildren
trial
conduct
winter
subject
follow
period
month
studi
japan
includ
healthi
schoolchildren
found
group
receiv
iu
daili
vitamin
period
signific
reduct
incid
influenza
compar
placebo
contrari
find
differ
influenza
b
incid
two
group
studi
infant
conduct
china
evalu
safeti
clinic
efficaci
two
dose
vitamin
prevent
season
influenza
healthi
infant
divid
two
group
receiv
oral
vitamin
period
month
either
low
iuday
high
dose
iuday
case
affect
influenza
viru
case
influenza
infect
occur
lowdos
highdos
vitamin
group
respect
signific
differ
outcom
infect
also
found
two
group
high
dose
result
rapid
relief
symptom
fever
cough
wheez
rapid
decreas
viral
load
diseas
recoveri
overal
conclud
iu
vitamin
daili
suitabl
prevent
season
influenza
anoth
random
trial
daili
high
dose
iu
versu
standard
dose
iu
vitamin
month
young
canadian
children
age
year
also
show
incid
influenza
infect
influenza
influenza
b
combin
highdos
group
reduc
incid
rr
ci
doubleblind
rct
mongolian
children
children
randomli
assign
differ
treatment
winter
one
hundr
four
children
assign
ingest
daili
unfortifi
regular
milk
control
group
children
milk
fortifi
iu
vitamin
case
studi
base
parent
report
mani
chest
infect
cold
children
past
month
author
found
vitamin
iu
daili
period
week
led
clinic
statist
signific
reduct
risk
parentreport
ari
overal
data
concern
whether
vitamin
supplement
may
reduc
incid
influenza
still
inconclus
reason
clinic
trial
investig
potenti
associ
vitamin
children
respiratori
infect
limit
sever
factor
variabl
dose
regimen
bolu
vs
daili
supplement
age
rang
preschool
vs
older
age
popul
healthi
unhealthi
particip
type
rti
aggreg
upper
lower
bacteri
viral
rti
outcom
measur
sever
durat
number
laboratori
confirm
rti
still
possibl
highdos
supplement
effect
prevent
urti
well
improv
outcom
certain
subpopul
exclud
although
mechan
vitamin
effect
immun
quit
complex
exist
data
support
notion
adequ
serum
oh
facilit
process
defens
immun
cell
bacteri
viral
infect
studi
includ
review
explor
associ
inadequ
oh
concentr
rti
role
vitamin
supplement
prevent
amelior
sever
rti
infant
young
children
evalu
result
complex
quit
difficult
due
heterogen
natur
studi
sever
factor
season
racial
differ
differ
cutoff
valu
differ
age
popul
studi
might
explain
reason
variat
result
studi
review
studi
vitamin
supplement
differ
dose
use
howev
studi
agre
decreas
serum
oh
concentr
preval
among
infant
child
patient
rti
vitamin
defici
associ
increas
rate
rti
may
proof
vitamin
deficiencyinsuffici
least
part
contribut
pathogenesi
sever
infecti
diseas
respiratori
tract
childhood
addit
avail
evid
normal
high
serum
oh
statu
appear
benefici
influenc
incid
sever
though
type
infect
could
therefor
effect
inexpens
mode
prophylaxi
infect
howev
studi
vitamin
supplement
young
children
produc
conflict
result
still
remain
unclear
whether
supplement
may
benefit
dose
far
success
outcom
report
children
tb
histori
recurr
aom
bronchiol
wherea
benefit
found
children
pneumonia
conflict
result
found
regard
influenza
studi
pharyngotonsil
rhinosinus
anoth
perspect
could
matern
vitamin
supplement
pregnanc
breastfeed
order
reduc
futur
rti
offspr
though
ideal
dose
supplement
still
difficult
defin
nevertheless
vitamin
import
everi
stage
life
especi
rapidli
grow
infant
teenag
pregnant
breastfeed
women
public
health
polici
put
practic
supplement
regard
common
rti
childhood
recommend
vitamin
supplement
gener
popul
depend
characterist
countri
appli
uniformli
even
throughout
europ
characterist
includ
skin
type
weather
dietari
dress
habit
may
influenc
decis
health
profession
recommend
dose
supplement
everi
individu
infant
patient
result
countri
europ
elsewher
establish
recommend
case
control
clinic
trial
need
prove
unequivoc
whether
serum
oh
concentr
strongli
associ
childhood
respiratori
infect
supplement
could
benefici
age
group
develop
specif
guidelin
